Botanix Pharmaceuticals Ltd has released a press release.
Suspension
Filed with ASX ·
On 6ix: 6ix.com/news/suspension-7
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Prospectus - Botanix Pharmaceuticals
- Human Clinical Study for an Oral Treatment for Osteoporosis
- Acquisition of Botanix Pharmaceuticals Inc
- Termination of Agreement to acquire Takor
- Takor Update - Mappt Update & Collaboration Opportunities
Later from Botanix Pharmaceuticals
- Reinstatement to Official Quotation - 15 July 2016
- Botanix Secures Commercial-Scale Synthetic Cannabidiol
- DEA Scheduling Decision Supports Botanix Approach
- Botanix Accelerates Clinical Program with First Human Study
- Botanix Announces Positive Human Trial Data
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals